Cargando…
Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background
Immunosenescence is a process of remodeling the immune system under the influence of chronic inflammation during aging. Parkinson’s disease (PD) is a common age-associated neurodegenerative disorder and is frequently accompanied by neuroinflammation. On the other hand, cytomegalovirus (CMV), one of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658620/ https://www.ncbi.nlm.nih.gov/pubmed/34884936 http://dx.doi.org/10.3390/ijms222313119 |
_version_ | 1784612773390450688 |
---|---|
author | Vavilova, Julia D. Boyko, Anna A. Ponomareva, Natalya V. Fokin, Vitaly F. Fedotova, Ekaterina Y. Streltsova, Maria A. Kust, Sofya A. Grechikhina, Maria V. Bril, Ekaterina V. Zimnyakova, Olga S. Kovalenko, Elena I. Sapozhnikov, Alexander M. |
author_facet | Vavilova, Julia D. Boyko, Anna A. Ponomareva, Natalya V. Fokin, Vitaly F. Fedotova, Ekaterina Y. Streltsova, Maria A. Kust, Sofya A. Grechikhina, Maria V. Bril, Ekaterina V. Zimnyakova, Olga S. Kovalenko, Elena I. Sapozhnikov, Alexander M. |
author_sort | Vavilova, Julia D. |
collection | PubMed |
description | Immunosenescence is a process of remodeling the immune system under the influence of chronic inflammation during aging. Parkinson’s disease (PD) is a common age-associated neurodegenerative disorder and is frequently accompanied by neuroinflammation. On the other hand, cytomegalovirus (CMV), one of the most spread infections in humans, may induce chronic inflammation which contributes to immunosenescence, differentiation and the inflation of T cells and NK cells. Currently, there is no clear understanding of immunosenescence severity in PD patients infected with CMV. In this study, we analyzed differentiation stages and immunosenescence characteristics of T cells and NK cells in 31 patients with mild and moderate PD severity, 33 age-matched and 30 young healthy donors. The PD patients were 100% CMV-seropositive compared to 76% age-matched and 73% young CMV-infected healthy donors. The proportion of effector memory T cells re-expressing CD45RA, CD57(+)CD56(−) T cells and CD57(+)CD56(+) T cells was significantly reduced in PD patients compared with CMV-seropositive age-matched healthy individuals. The CD57(+)CD56(−) T cell proportion in PD patients was similar to that of CMV-seropositive young healthy donors. Thus, PD is characterized by reduced peripheral blood T cell immunosenescence, even against the background of CMV infection. |
format | Online Article Text |
id | pubmed-8658620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86586202021-12-10 Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background Vavilova, Julia D. Boyko, Anna A. Ponomareva, Natalya V. Fokin, Vitaly F. Fedotova, Ekaterina Y. Streltsova, Maria A. Kust, Sofya A. Grechikhina, Maria V. Bril, Ekaterina V. Zimnyakova, Olga S. Kovalenko, Elena I. Sapozhnikov, Alexander M. Int J Mol Sci Article Immunosenescence is a process of remodeling the immune system under the influence of chronic inflammation during aging. Parkinson’s disease (PD) is a common age-associated neurodegenerative disorder and is frequently accompanied by neuroinflammation. On the other hand, cytomegalovirus (CMV), one of the most spread infections in humans, may induce chronic inflammation which contributes to immunosenescence, differentiation and the inflation of T cells and NK cells. Currently, there is no clear understanding of immunosenescence severity in PD patients infected with CMV. In this study, we analyzed differentiation stages and immunosenescence characteristics of T cells and NK cells in 31 patients with mild and moderate PD severity, 33 age-matched and 30 young healthy donors. The PD patients were 100% CMV-seropositive compared to 76% age-matched and 73% young CMV-infected healthy donors. The proportion of effector memory T cells re-expressing CD45RA, CD57(+)CD56(−) T cells and CD57(+)CD56(+) T cells was significantly reduced in PD patients compared with CMV-seropositive age-matched healthy individuals. The CD57(+)CD56(−) T cell proportion in PD patients was similar to that of CMV-seropositive young healthy donors. Thus, PD is characterized by reduced peripheral blood T cell immunosenescence, even against the background of CMV infection. MDPI 2021-12-04 /pmc/articles/PMC8658620/ /pubmed/34884936 http://dx.doi.org/10.3390/ijms222313119 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vavilova, Julia D. Boyko, Anna A. Ponomareva, Natalya V. Fokin, Vitaly F. Fedotova, Ekaterina Y. Streltsova, Maria A. Kust, Sofya A. Grechikhina, Maria V. Bril, Ekaterina V. Zimnyakova, Olga S. Kovalenko, Elena I. Sapozhnikov, Alexander M. Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title | Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title_full | Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title_fullStr | Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title_full_unstemmed | Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title_short | Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background |
title_sort | reduced immunosenescence of peripheral blood t cells in parkinson’s disease with cmv infection background |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658620/ https://www.ncbi.nlm.nih.gov/pubmed/34884936 http://dx.doi.org/10.3390/ijms222313119 |
work_keys_str_mv | AT vavilovajuliad reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT boykoannaa reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT ponomarevanatalyav reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT fokinvitalyf reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT fedotovaekaterinay reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT streltsovamariaa reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT kustsofyaa reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT grechikhinamariav reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT brilekaterinav reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT zimnyakovaolgas reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT kovalenkoelenai reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground AT sapozhnikovalexanderm reducedimmunosenescenceofperipheralbloodtcellsinparkinsonsdiseasewithcmvinfectionbackground |